Navigation Links
FDA OKs Expanded Use of Prostate Cancer Drug
Date:12/10/2012

MONDAY, Dec. 10 (HealthDay News) -- The approved use of the drug Zytiga has been expanded to include treatment of men with late-stage, hormone therapy-resistant prostate cancer before they undergo chemotherapy, the U.S. Food and Drug Administration announced Monday.

Zytiga was initially approved in April 2011 for treatment of prostate cancer patients whose disease had progressed after treatment with the chemotherapy drug docetaxel.

The drug decreases production of the male sex hormone testosterone. In prostate cancer, testosterone stimulates prostate tumors to grow. Drugs or surgery are used to reduce testosterone production or to block the hormone's effects.

However, some men have what's called "castration-resistant" or hormone therapy-resistant prostate cancer, which means that prostate cancer cells continue to grow even with low levels of testosterone, the FDA explained in a news release.

The expanded approval is based on a study of 1,088 men with late-stage, hormone therapy-resistant prostate cancer who took either Zytiga (abiraterone acetate) or an inactive placebo in combination with another drug called prednisone.

Median overall survival was just over 35 months for patients who took Zytiga and about 30 months for those who took the placebo, the FDA noted.

The most common side effects among patients taking Zytiga included fatigue, joint discomfort, swelling caused by fluid retention, hot flush, diarrhea, vomiting, cough, high blood pressure, shortness of breath, urinary tract infection and bruising.

This expanded approval of Zytiga was made under the FDA's priority review program, which offers an accelerated six-month review for drugs that may offer major advances in treatment or provide a treatment when no adequate therapy exists.

"Today's approval demonstrates the benefit of further evaluating a drug in an earlier disease setting and provides patients and health care providers the
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Prostate cancer now detectable by imaging-guided biopsy
2. Targeted prostate biopsy has potential to improve diagnosis of prostate cancer
3. The Project for Natural Health Choices Inc. Issues an Advisory for Men to Consume Flavonoids in their Diet to Protect Against Prostate Cancer
4. Targeted Prostate Cancer Biopsies Might Improve Care: Study
5. Longer life expectancy, aging population necessitate new strategies for prostate cancer care
6. Drug shows promise in prostate cancer spread to bone
7. Clinical trial at GHSU Cancer Center targets advanced prostate cancer
8. COUP-TFII sparks prostate cancer progression
9. UAlberta prostate cancer researcher and team developing homing beacon drugs to target cancer cells
10. Prostate Cancer Websites Often Hard to Understand: Study
11. Mayo Clinic gets FDA approval for new imaging agent for recurrent prostate cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/26/2014)... December 26, 2014 DW-InductionHeating.com (DaWei Induction ... designing, researching and developing, producing and marketing of a ... the business announces their new series of induction ... of the company, induction brazing refers to ... special filler material and heat. The manager says that ...
(Date:12/25/2014)... The microscopy market is estimated to grow at ... by 2019. Optical microscopy is the largest segment ... segment is expected to show the fastest growth ... nanotechnology, technological advancements, and increasing federal support to ... Full Copy of Report @ http://www.marketsandmarkets.com/Market-Reports/world-microscopy-399.html ...
(Date:12/25/2014)... The click strand woven bamboo ... durability. Today, the business announces a click strand ... Jan. 30, 2015. , Click strand woven bamboo ... is a well-known brand in the bamboo industry. ... a reliable bamboo flooring supplier. , “We are ...
(Date:12/25/2014)... Dallas, TX (PRWEB) December 26, 2014 ... Analysis to 2023” focuses on the current treatment landscape, ... colorectal cancer market. TS-1 is an anti-cancer drug which ... administered orally and is also used for treating gastric ... gimestat and otastat potassium. The drug was first approved ...
(Date:12/25/2014)... “Every three months the trends for ... evening dress will be one of the hottest styles in ... says. Today, the company releases 26 A-line sweetheart evening dresses, ... off. , “We are trying our best to help ... latest designs. Along with affordable prices, we provide discounted delivery ...
Breaking Medicine News(10 mins):Health News:Induction Brazing Equipment Series From DaWei Induction Heating Co., A Reliable Supplier Of Induction Heating Equipment 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3
... Surgery International Sends First American for Prostate Cancer ... American Surgical Team to TrinidadU.S. Risk Issues First ... Fla. and DALLAS, March 11 An uninsured ... last week for prostate cancer surgery -- to ...
... Lower Cost Female Condom Increases Access to Woman-Initiated ... Health Company (NYSE Alternext: FHC) today announced approval ... for the company,s FC2 Female Condom(R) (FC2), a ... sexually transmitted infections (STIs), HIV/AIDS, and unintended pregnancy. ...
... Claims Processing and PaymentBROOMFIELD, Colo., March 11 ... LVLT ) today announced that it has ... management services company, to provide that company,s primary network ... Level 3 will deliver direct Internet access and voice ...
... Credentials in Two States to Complex RehabDAYTON, Ohio, March ... specialist with 10 years of experience, has joined ... nation,s fastest growing accredited complex rehab companies. Witten is ... Ohio, for ASM ( www.alliance-seating.com ) and provides power ...
... alliance enables the direct sales of safe, high-quality ... March 11 It,s always been easy to ... recognize the value behind reusable Therma-Kool(R) Hot & ... Cold Packs. The therapy packs provide immediate relief ...
... More Exercise and Lose Weight NAPLES, Fla., March 11 ... and wellness resource, are helping all Hoosiers begin building ... nothing. Principals Stacy Bick and Rebecca Johnson are offering all ... www.youcanmakeitfit.com for only 99 cents a month if they ...
Cached Medicine News:Health News:Modern Health Care Economics is Driving Inventiveness in Delivery of Cancer Surgery and Management of Risk 2Health News:Modern Health Care Economics is Driving Inventiveness in Delivery of Cancer Surgery and Management of Risk 3Health News:Female Health Company Receives FDA Approval for FC2 Female Condom(R) 2Health News:Female Health Company Receives FDA Approval for FC2 Female Condom(R) 3Health News:Female Health Company Receives FDA Approval for FC2 Female Condom(R) 4Health News:Female Health Company Receives FDA Approval for FC2 Female Condom(R) 5Health News:Female Health Company Receives FDA Approval for FC2 Female Condom(R) 6Health News:Level 3 Provides Primary Connectivity for MDI Holdings 2Health News:Level 3 Provides Primary Connectivity for MDI Holdings 3Health News:Nurse & Veteran Rehab Specialist, Terri Witten, Joins Fast-Growing Alliance Seating & Mobility in Ohio 2Health News:Nortech Labs, Inc. and MEDNET(TM) Make for a Notable, Natural Partnership 2Health News:Nortech Labs, Inc. and MEDNET(TM) Make for a Notable, Natural Partnership 3Health News:Make It Fit America Inc. Offers Virtually Free Fitness Service on 'Make Indiana Fit Day' 2Health News:Make It Fit America Inc. Offers Virtually Free Fitness Service on 'Make Indiana Fit Day' 3
(Date:12/24/2014)... MASON, Ohio , Dec. 23, 2014 /PRNewswire/ ... industry-leading treatment decision support to healthcare providers for ... that it has secured $30 million in equity ... Virginia C. Drosos , President and Chief ... increased clinical adoption and development of Assurex Health,s ...
(Date:12/24/2014)... Va. , Dec. 23, 2014  The ... diastolic blood pressure target for people with diabetes ... moderate or high doses of statins, in keeping ... management enacted by the American College of Cardiology ... are reflected in the most recent changes to ...
(Date:12/24/2014)... BARBARA, Calif. , Dec. 23, 2014 In ... Junior Doctors, Association of Sierra Leone , ... Sierra Leone for the treatment of local health ... While a new dedicated Ebola care center was constructed ... virus, the facility is not available for local Sierra Leonean ...
Breaking Medicine Technology:Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 2New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 4First Ebola Treatment Unit for Local Health Workers Arrives in Sierra Leone 2
... UPPSALA, Sweden, January 13 Beactica AB, the ... research,collaboration agreement with GE Healthcare (Chalfont St. Giles, ... tools, and Uppsala,University (Sweden). The collaboration ... GE Healthcare,s Biacore(TM) technology with,enzymology expertise from ...
... Life League,s historic Personhood Conference is featuring ... cell research and regenerative medicine.(Logo: ... CEO of AVM Biotechnology and President of ... over 17 years of experience in scientific ...
Cached Medicine Technology:Beactica Announces Fragment-Based Drug Discovery Research Collaboration With GE Healthcare and Uppsala University 2Stem Cell Pioneer to Speak to A.L.L. Personhood Conference 2
... a scientifically advanced multinutrient that ... and full body health. It ... including a diverse array of ... lycopene and OptiBerry and important ...
... Ocuvite® Extra vitamin and mineral supplements ... original formula plus more. Ocuvite ... and higher levels of vitamins C ... also contains other antioxidants and minerals ...
HydroEye is an exclusive formulation designed to provide dry eye relief and support the body's natural tear formation. Like all ScienceBased Health formulations, it is produced in softgel form for ma...
Expert QC data management solution...
Medicine Products: